1816331-66-4
|
|
- CAS号:
- 1816331-66-4
- 英文名:
- GSK864
- 英文别名:
- GSK864;GSK864,GSK-864;GSK864 >=98% (HPLC);1H-Pyrazolo[4,3-c]pyridine-3,7-dicarboxamide, 1-[(4-fluorophenyl)methyl]-4,5,6,7-tetrahydro-N3-(4-methoxy-3,5-dimethylphenyl)-7-methyl-5-(1H-pyrrol-2-ylcarbonyl)-, (7S)-
- 中文名:
- 1816331-66-4
- 中文别名:
- 化合物 T15442;异柠檬酸脱氢酶1(IDH1)突变体抑制剂(GSK864)
- CBNumber:
- CB63171695
- 分子式:
- C30H31FN6O4
- 分子量:
- 558.6
- MOL File:
- 1816331-66-4.mol
|
|
|
1816331-66-4化学性质
-
沸点:
-
782.9±60.0 °C(Predicted)
-
|
-
密度:
-
1.37±0.1 g/cm3(Predicted)
-
|
-
储存条件:
-
2-8°C
-
|
-
溶解度:
-
DMF:20.0(Max Conc. mg/mL);35.8(Max Conc. mM)
DMSO:60.0(Max Conc. mg/mL);107.41(Max Conc. mM) Ethanol:20.0(Max Conc. mg/mL);35.8(Max Conc. mM) Ethanol:PBS (pH 7.2) (1:1):0.5(Max Conc. mg/mL);0.9(Max Conc. mM)-
|
-
酸度系数(pKa):
-
11.73±0.70(Predicted)
-
|
-
形态:
-
powder
-
|
-
颜色:
-
white to beige
-
|
-
旋光性 (optical activity):
-
[α]/D -66 to -76°, c = 0.5 in methanol
-
|
1816331-66-4性质、用途与生产工艺
GSK864是异柠檬酸脱氢酶1 (IDH1) 突变体抑制剂; 抑制IDH1突变体R132C,R132H和R132G的IC50值分别为8.8,15.2和16.6 nM。
IC50: 8.8 nM (IDH1 mutants R132C), 15.2 nM (IDH1 mutants R132H), 16.6 nM (IDH1 mutants R132G)
GSK864 inhibits 2-HG production in R132C IDH1 mutant HT1080 fibrosarcoma cells with an EC
50
of 320 nM by LCMS/MS analysis.
Following intraperitoneal (IP) administration in CD-1 mice, significant concentrations of GSK864 are maintained in peripheral blood samples of mice for up to 24 hours. Analysis of BM cells for expression of markers of early differentiation reveals slightly increased numbers of huCD45
+
CD38
+
cells in R132C or R132H IDH1 mutant engrafted mice treated with GSK864.
1816331-66-4
上下游产品信息
上游原料
下游产品
更新日期 | 产品编号 | 产品名称 | CAS编号 | 包装 | 价格 |
---|
2024/01/25 | HY-19540 | 1816331-66-4 GSK864 | 1816331-66-4 | 2mg | 850元 |
2024/01/25 | HY-19540 | 1816331-66-4 GSK864 | 1816331-66-4 | 5mg | 2000元 |
1816331-66-4, 1816331-66-4 相关搜索:
- 抑制剂
- 细胞生物学试剂
- C30H31FN6O4
- 化合物 T15442
- 异柠檬酸脱氢酶1(IDH1)突变体抑制剂(GSK864)
- 1816331-66-4
- GSK864,GSK-864
- GSK864 >=98% (HPLC)
- 1H-Pyrazolo[4,3-c]pyridine-3,7-dicarboxamide, 1-[(4-fluorophenyl)methyl]-4,5,6,7-tetrahydro-N3-(4-methoxy-3,5-dimethylphenyl)-7-methyl-5-(1H-pyrrol-2-ylcarbonyl)-, (7S)-
- GSK864